Revenue Recognition (Tables)

3 Months Ended

Mar. 31, 2020

Revenue From Contract With Customer [Abstract]

Schedule of Company's Revenue for Reportable Segment by Country Based on Locations of Customer

The following represents the Company’s revenue for its reportable segment by country, based on the locations of the customer.

	For the Three Months Ended March 31, 2020
	(In Thousands)
	Oncology Innovation Platform		Global Supply Chain Platform		Commercial Platform		Consolidated Total
China	$	28,308	$	205	$	—	$	28,513
United States		—		1,980		15,542		17,522
Other foreign countries		79		821		—		900
Total revenue	$	28,387	$	3,006	$	15,542	$	46,935

	For the Three Months Ended March 31, 2019
	(In Thousands)
	Oncology Innovation Platform		Global Supply Chain Platform		Commercial Platform		Consolidated Total
United States	$	—	$	5,660	$	14,675	$	20,335
Austria		—		2,173		—		2,173
United Kingdom		—		1,023		—		1,023
India		—		777		—		777
China		144		242		—		386
Other foreign countries		—		613		—		613
Total revenue	$	144	$	10,488	$	14,675	$	25,307

Summary of Receivables and Contract Liabilities From Contracts with Customers

The following table provides information about receivables and contract liabilities from contracts with customers. The Company has not recorded any contract assets from contracts with customers.

	March 31, 2020			December 31, 2019
	(In Thousands)
Accounts receivable, gross	$	66,406		$	31,207
Chargebacks and other deductions		(14,858	)		(14,394	)
Provision for credit losses		(130	)		(124	)
Accounts receivable, net	$	51,418		$	16,689
Deferred revenue		75			218
Total contract liabilities	$	75		$	218

Summary of Accounts Receivable and Contract Asset Balances by Reportable Segments

The following tables illustrate accounts receivable and contract asset balances by reportable segments.

	March 31, 2020
	(In Thousands)
	Oncology Innovation Platform		Global Supply Chain Platform			Commercial Platform			Consolidated Total
Accounts receivable, gross	$	30,110	$	1,505		$	34,791		$	66,406
Chargebacks and other deductions		—		(1	)		(14,857	)		(14,858	)
Provision for credit losses		—		(116	)		(14	)		(130	)
Accounts receivable, net		30,110		1,388			19,920			51,418

	December 31, 2019
	(In Thousands)
	Oncology Innovation Platform		Global Supply Chain Platform			Commercial Platform			Consolidated Total
Accounts receivable, gross	$	49	$	1,522		$	29,636		$	31,207
Chargebacks and other deductions		—		(1	)		(14,393	)		(14,394	)
Provision for credit losses		—		(114	)		(10	)		(124	)
Accounts receivable, net	$	49	$	1,407		$	15,233		$	16,689